Works matching IS 01676997 AND DT 2012 AND VI 30 AND IP 1

Results: 98

A short report on article by V. Pruliere-Escabasse et al., Vol. 27: 285-286, 2009.

Published in:

2012

By:

Davidson TM

Publication type:

Journal Article

Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53 (mutated) B malignant cells.

Published in:

2012

By:

Bosco R;
Rabusin M;
Voltan R;
Celeghini C;
Corallini F;
Capitani S;
Secchiero P

Publication type:

Journal Article

Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer.

Published in:

2012

By:

Jeong JH;
Jung SY;
Park IH;
Lee KS;
Kang HS;
Kim SW;
Kwon Y;
Kim EA;
Ko KL;
Nam BH;
Lee S;
Ro J

Publication type:

Journal Article

In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody.

Published in:

2012

By:

Zauli G;
Corallini F;
Zorzet S;
Grill V;
Marzari R;
Secchiero P

Publication type:

Journal Article

Combined treatment with Bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients.

Published in:

2012

By:

Tsavaris N;
Voutsas IF;
Kosmas C;
Gritzapis AD;
Baxevanis CN

Publication type:

Journal Article

Circulating thrombospondin 1 level as a surrogate marker in patients receiving cyclophosphamide-based metronomic chemotherapy.

Published in:

2012

By:

Lansiaux A;
Salingue S;
Dewitte A;
Clisant S;
Penel N

Publication type:

Journal Article

An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma.

Published in:

2012

By:

Kim GP;
Mahoney MR;
Szydlo D;
Mok TS;
Marshke R;
Holen K;
Picus J;
Boyer M;
Pitot HC;
Rubin J;
Philip PA;
Nowak A;
Wright JJ;
Erlichman C

Publication type:

Journal Article

Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium.

Published in:

2012

By:

Kindler HL;
Wroblewski K;
Wallace JA;
Hall MJ;
Locker G;
Nattam S;
Agamah E;
Stadler WM;
Vokes EE

Publication type:

Journal Article

Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients.

Published in:

2012

By:

Coriat R;
Mir O;
Cessot A;
Brezault C;
Ropert S;
Durand JP;
Cacheux W;
Chaussade S;
Goldwasser F

Publication type:

Journal Article

Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity.

Published in:

2012

By:

Kim SJ;
Kim K;
Park Y;
Kim BS;
Huh J;
Ko YH;
Park K;
Suh C;
Kim WS

Publication type:

Journal Article

A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma.

Published in:

2012

By:

Shepard DR;
Cooney MM;
Elson P;
Bukowski RM;
Dreicer R;
Rini BI;
Garcia JA

Publication type:

Journal Article

A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer.

Published in:

2012

By:

Lee SS;
Jeung HC;
Chung HC;
Noh SH;
Hyung WJ;
Ahn JY;
Rha SY

Publication type:

Journal Article

A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.

Published in:

2012

By:

Pacey S;
Gore M;
Chao D;
Banerji U;
Larkin J;
Sarker S;
Owen K;
Asad Y;
Raynaud F;
Walton M;
Judson I;
Workman P;
Eisen T

Publication type:

Journal Article

A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer.

Published in:

2012

By:

Oh SY;
Kwon HC;
Jeong SH;
Joo YT;
Lee YJ;
Hee Cho S;
Kang MH;
Go SI;
Lee GW;
Gu Kim H;
Kang JH

Publication type:

Journal Article

Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma.

Published in:

2012

By:

Molina AM;
Feldman DR;
Ginsberg MS;
Kroog G;
Tickoo SK;
Jia X;
Georges M;
Patil S;
Baum MS;
Reuter VE;
Motzer RJ

Publication type:

Journal Article

A Comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors.

Published in:

2012

By:

Naing A;
Kurzrock R;
Adams LM;
Kleha JF;
Laubscher KH;
Bonate PL;
Weller S;
Fitzgerald C;
Xu Y;
Lorusso PM

Publication type:

Journal Article

Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies.

Published in:

2012

By:

Hammond-Thelin LA;
Thomas MB;
Iwasaki M;
Abbruzzese JL;
Lassere Y;
Meyers CA;
Hoff P;
de Bono J;
Norris J;
Matsushita H;
Mita A;
Rowinsky EK

Publication type:

Journal Article

Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer.

Published in:

2012

By:

Kim C;
Lee JL;
Choi YH;
Kang BW;
Ryu MH;
Chang HM;
Kim TW;
Kang YK

Publication type:

Journal Article

A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors.

Published in:

2012

By:

Vilar E;
Grünwald V;
Schöffski P;
Singer H;
Salazar R;
Iglesias JL;
Casado E;
Cullell-Young M;
Baselga J;
Tabernero J

Publication type:

Journal Article

Phase I study of oral irinotecan as a single-agent and given sequentially with capecitabine.

Published in:

2012

By:

Goff LW;
Benson AB 3rd;
Lorusso PM;
Tan AR;
Berlin JD;
Denis LJ;
Benner RJ;
Yin D;
Rothenberg ML

Publication type:

Journal Article

A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor.

Published in:

2012

By:

Yang SH;
Lin CC;
Lin ZZ;
Tseng YL;
Hong RL

Publication type:

Journal Article

Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers.

Published in:

2012

By:

Pithavala YK;
Tong W;
Mount J;
Rahavendran SV;
Garrett M;
Hee B;
Selaru P;
Sarapa N;
Klamerus KJ

Publication type:

Journal Article

A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors.

Published in:

2012

By:

Wang-Gillam A;
Arnold SM;
Bukowski RM;
Rothenberg ML;
Cooper W;
Wang KK;
Gauthier E;
Lockhart AC

Publication type:

Journal Article

Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors.

Published in:

2012

By:

Saraiya B;
Chugh R;
Karantza V;
Mehnert J;
Moss RA;
Savkina N;
Stein MN;
Baker LH;
Chenevert T;
Poplin EA

Publication type:

Journal Article

Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies.

Published in:

2012

By:

Schneider BJ;
Kalemkerian GP;
Bradley D;
Smith DC;
Egorin MJ;
Daignault S;
Dunn R;
Hussain M

Publication type:

Journal Article

Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs.

Published in:

2012

By:

Huang JJ;
Li ZM;
Huang Y;
Tian Y;
He XX;
Xiao J;
Lin TY

Publication type:

Journal Article

A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis.

Published in:

2012

By:

Moktan S;
Ryppa C;
Kratz F;
Raucher D

Publication type:

Journal Article

Adding a combination of hydroxycitrate and lipoic acid (METABLOC[TM]) to chemotherapy improves effectiveness against tumor development: experimental results and case report.

Published in:

2012

By:

Guais A;
Baronzio G;
Sanders E;
Campion F;
Mainini C;
Fiorentini G;
Montagnani F;
Behzadi M;
Schwartz L;
Abolhassani M

Publication type:

Journal Article

Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II.

Published in:

2012

By:

Xue X;
Qu XJ;
Gao ZH;
Sun CC;
Liu HP;
Zhao CR;
Cheng YN;
Lou HX

Publication type:

Journal Article

The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma.

Published in:

2012

By:

Levy AG;
Zage PE;
Akers LJ;
Ghisoli ML;
Chen Z;
Fang W;
Kannan S;
Graham T;
Zeng L;
Franklin AR;
Huang P;
Zweidler-McKay PA

Publication type:

Journal Article

Antiangiogenic properties of an unusual benzo[k,l]xanthene lignan derived from CAPE (Caffeic Acid Phenethyl Ester)

Published in:

2012

By:

Basini G;
Baioni L;
Bussolati S;
Grasselli F;
Daquino C;
Spatafora C;
Tringali C

Publication type:

Journal Article

A novel aminosteroid of the 5[alpha]-androstane-3[alpha],17[beta]-diol family induces cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.

Published in:

2012

By:

Jegham H;
Roy J;
Maltais R;
Desnoyers S;
Poirier D

Publication type:

Journal Article

Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents.

Published in:

2012

By:

Li WT;
Hwang DR;
Song JS;
Chen CP;
Chen TW;
Lin CH;
Chuu JJ;
Lien TW;
Hsu TA;
Huang CL;
Tseng HY;
Lin CC;
Lin HL;
Chang CM;
Chao YS;
Chen CT

Publication type:

Journal Article

Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.

Published in:

2012

By:

Leguerney I;
Lassau N;
Koscielny S;
Rodrigues M;
Massard C;
Rouffiac V;
Benatsou B;
Thalmensi J;
Bawa O;
Opolon P;
Peronneau P;
Roche A

Publication type:

Journal Article

Functional properties of synthetic N-acyl-L-homoserine lactone analogs of quorum-sensing gram-negative bacteria on the growth of human oral squamous carcinoma cells.

Published in:

2012

By:

Chai H;
Hazawa M;
Shirai N;
Igarashi J;
Takahashi K;
Hosokawa Y;
Suga H;
Kashiwakura I

Publication type:

Journal Article

The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity.

Published in:

2012

By:

Tarasenko N;
Kessler-Icekson G;
Boer P;
Inbal A;
Schlesinger H;
Phillips DR;
Cutts SM;
Nudelman A;
Rephaeli A

Publication type:

Journal Article

Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A.

Published in:

2012

By:

Wilmes A;
Chan A;
Rawson P;
William Jordan T;
Miller JH

Publication type:

Journal Article

3[beta]-acetyl tormentic acid induces apoptosis of resistant leukemia cells independently of P-gp/ABCB1 activity or expression.

Published in:

2012

By:

Rocha Gda G;
Simoes M;
Oliveira RR;
Kaplan MA;
Gattass CR

Publication type:

Journal Article

Cytotoxic activity of the titanium alkoxide (OPy)(2)Ti(4AP) (2) against cancer colony forming cells.

Published in:

2012

By:

Williamson EA;
Boyle TJ;
Raymond R;
Farrington J;
Verschraegen C;
Shaheen M;
Hromas R

Publication type:

Journal Article

Salarin C, a member of the salarin superfamily of marine compounds, is a potent inducer of apoptosis.

Published in:

2012

By:

Ben-Califa N;
Bishara A;
Kashman Y;
Neumann D

Publication type:

Journal Article

Expression of Nur77 induced by an n-butylidenephthalide derivative promotes apoptosis and inhibits cell growth in oral squamous cell carcinoma.

Published in:

2012

By:

Liu PY;
Sheu JJ;
Lin PC;
Lin CT;
Liu YJ;
Ho LI;
Chang LF;
Wu WC;
Chen SR;
Chen J;
Harn YC;
Lin SZ;
Tsai CH;
Chiou TW;
Harn HJ

Publication type:

Journal Article

Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab.

Published in:

2012

By:

Gardner ER;
Kelly M;
Springman E;
Lee KJ;
Li H;
Moore W;
Figg WD

Publication type:

Journal Article

17[alpha]-Alkynyl 3[alpha], 17[beta]-androstanediol non-clinical and clinical pharmacology, pharmacokinetics and metabolism.

Published in:

2012

By:

Ahlem C;
Kennedy M;
Page T;
Bell D;
Delorme E;
Villegas S;
Reading C;
White S;
Stickney D;
Frincke J

Publication type:

Journal Article

Nutlin-1 strengthened anti-proliferation and differentiation-inducing activity of ATRA in ATRA-treated p-glycoprotein deregulated human myelocytic leukemia cells.

Published in:

2012

By:

Zhang L;
Yan Y;
Zhu D;
Yang W;
Wang W;
Hu Y;
Yang B;
He Q

Publication type:

Journal Article

K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr Virus (EBV)-associated nasopharyngeal carcinoma cells.

Published in:

2012

By:

Ng YK;
Wong EY;
Lau CP;
Chan JP;
Wong SC;
Chan AS;
Kwan MP;
Tsao SW;
Tsang CM;
Lai PB;
Chan AT;
Lui VW

Publication type:

Journal Article

Histone deacetylase inhibitors enhance the anticancer activity of nutlin-3 and induce p53 hyperacetylation and downregulation of MDM2 and MDM4 gene expression.

Published in:

2012

By:

Palani CD;
Beck JF;
Sonnemann J

Publication type:

Journal Article

Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin.

Published in:

2012

By:

Zhao Y;
Wang C;
Wu Z;
Fang J;
Zhu L

Publication type:

Journal Article

Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivative.

Published in:

2012

By:

Zhang Y;
Zhang H;
Chen J;
Zhao H;
Zeng X;
Qing C

Publication type:

Journal Article

The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model.

Published in:

2012

By:

Yu J;
Lee HJ;
Hur K;
Kwak MK;
Han TS;
Kim WH;
Song SC;
Yanagihara K;
Yang HK

Publication type:

Journal Article

A short report on article by V. Pruliere-Escabasse et al., Vol. 27: 285-286, 2009.

Published in:

Investigational New Drugs, 2012, v. 30, n. 1, p. 423, doi. 10.1007/s10637-010-9434-2

By:

Davidson, Terence

Publication type:

Article